ConductScience.org, home

Paper39757201

GPR40-full agonist AM1638 alleviates palmitate-induced oxidative damage in H9c2 cells via an AMPK-dependent pathway.

Yun S and 9 others. BMB Rep, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. GPR40-full agonist AM1638 alleviates palmitate-induced oxidative damage in H9c2 cells via an AMPK-dependent pathway. Papers, record 39757201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39757201

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
GPR40-full agonist AM1638 alleviates palmitate-induced oxidative damage in H9c2 cells via an AMPK-dependent pathway.
PubMed
Journal
BMB Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-06-10
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yun SSukHwan
2Kim JWJoo Won
3Park MJMin Jeong
4Song EEyun
5Jang SYSoo Yeon
6Jang AAhreum
7Choi KMKyung Mook
8Baik SHSei Hyun
9Hwang HJHwan-Jin
10Yoo HJHye Jin

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Oxidative StressMajor topic
Receptors, G-Protein-CoupledMajor topic
AMP-Activated Protein KinasesMajor topic
PalmitatesMajor topic
Animals
Rats
Myocytes, Cardiac
Cell Line
Signal Transduction
Membrane Potential, Mitochondrial
Cell Survival
Phosphorylation
Apoptosis

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135067013GPR40 Agonism Modulates Inflammatory Reactions in Vascular Endothelial Cells.Diabetes Metab J2022https://conductscience.org/library/papers/35067013PubMed
220141097Cardiomyopathy: an overview.Am Fam Physician2009https://conductscience.org/library/papers/20141097PubMed
324096871Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance.Cell Death Differ2013https://conductscience.org/library/papers/24096871PubMed
435040256Mitophagy-regulated mitochondrial health strongly protects the heart against cardiac dysfunction after acute myocardial infarction.J Cell Mol Med2022https://conductscience.org/library/papers/35040256PubMed
532719069The GPR40 Full Agonist SCO-267 Improves Liver Parameters in a Mouse Model of Nonalcoholic Fatty Liver Disease without Affecting Glucose or Body Weight.J Pharmacol Exp Ther2020https://conductscience.org/library/papers/32719069PubMed
625685685GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo.Mol Metab2015https://conductscience.org/library/papers/25685685PubMed
735203602Involvement of Oxidative Stress in the Development of Subcellular Defects and Heart Disease.Biomedicines2022https://conductscience.org/library/papers/35203602PubMed
829695780Structural basis for GPR40 allosteric agonism and incretin stimulation.Nat Commun2018https://conductscience.org/library/papers/29695780PubMed
927121981GPR40 agonist ameliorates liver X receptor-induced lipid accumulation in liver by activating AMPK pathway.Sci Rep2016https://conductscience.org/library/papers/27121981PubMed
1027138700HO-1 Protects against Hypoxia/Reoxygenation-Induced Mitochondrial Dysfunction in H9c2 Cardiomyocytes.PLoS One2016https://conductscience.org/library/papers/27138700PubMed
1130291911Augmentation of NAD+ levels by enzymatic action of NAD(P)H quinone oxidoreductase 1 attenuates adriamycin-induced cardiac dysfunction in mice.J Mol Cell Cardiol2018https://conductscience.org/library/papers/30291911PubMed
1222833723Heme oxygenase-1, oxidation, inflammation, and atherosclerosis.Front Pharmacol2012https://conductscience.org/library/papers/22833723PubMed
1324666736CNX-011-67, a novel GPR40 agonist, enhances glucose responsiveness, insulin secretion and islet insulin content in n-STZ rats and in islets from type 2 diabetic patients.BMC Pharmacol Toxicol2014https://conductscience.org/library/papers/24666736PubMed
1433262575Agonism of Gpr40 Protects the Capacities of Epidermal Stem Cells (ESCs) Against Ultraviolet-B (UV-B).Drug Des Devel Ther2020https://conductscience.org/library/papers/33262575PubMed
1531857574Mitochondrial dysfunction and oxidative stress in heart disease.Exp Mol Med2019https://conductscience.org/library/papers/31857574PubMed
1624974801Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function.BMC Cell Biol2014https://conductscience.org/library/papers/24974801PubMed
1719808358Control by circulating factors of mitochondrial function and transcription cascade in heart failure: a role for endothelin-1 and angiotensin II.Circ Heart Fail2009https://conductscience.org/library/papers/19808358PubMed
1831395314Cardiac Metabolic Limitations Contribute to Diminished Performance of the Heart in Aging.Biophys J2019https://conductscience.org/library/papers/31395314PubMed
1934497589GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34497589PubMed
2037915121AM1638, a GPR40-Full Agonist, Inhibited Palmitate- Induced ROS Production and Endoplasmic Reticulum Stress, Enhancing HUVEC Viability in an NRF2-Dependent Manner.Endocrinol Metab (Seoul)2023https://conductscience.org/library/papers/37915121PubMed

See all 34 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42444033GW9508-Induced Activation of GPR40 in Thymic Epithelial Cells: A Therapeutic Strategy to Delay Thymic Aging.Aging Cell2026https://conductscience.org/library/papers/42444033PubMed
42371471Activation of G protein-coupled receptor 40 alleviates STAT6 activation, airway inflammation and mucus hypersecretion in allergic asthma.Curr Res Pharmacol Drug Discov2026https://conductscience.org/library/papers/42371471PubMed
42008849The zinc-nitric oxide axis in acute brain injury: Convergent oxidative-nitrative stress, peroxynitrite signaling, and therapeutic targets.Redox Biol2026https://conductscience.org/library/papers/42008849PubMed
415520104-HNE-induced cellular dysfunction from lipid peroxidation: a potential therapeutic target in diabetic cardiomyopathy.Front Cell Dev Biol2025https://conductscience.org/library/papers/41552010PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39757201

GET https://conductscience.org/api/papers/v1/39757201/references?page=2